glp 1 agonist drugs mechanism of action of GLP-1 agonists – My Endo Consult What is GLP-1 and Its

Holsts laboratory played a central role in characterizing the active intestinal form of GLP-1, demonstrating its therapeutic potential in diabetes, as well as obesity treatment, and developing early drug analogs

Both are compounded and customized to your dosing needs

3 Nutrient deficiencies are a higher risk for those taking GLP-1 agonists because of decreased appetite and reduced food intake

Conclusions GLP1-RA reduce the risk of MACE by 14% in eight CVOTs with 60,080 patients with T2DM over a period ranging from 1.3 to 5.4 years

doi: 10.1002/ejhf.657

Patients may experience dehydration or related complications during GLP-1 therapy